Page last updated: 2024-10-23

bevantolol and Chronic Disease

bevantolol has been researched along with Chronic Disease in 2 studies

bevantolol: structure given in first source
bevantolol : A propanolamine that is 3-aminopropane-1,2-diol in which the hydrogen of the primary hydroxy group is substituted by 3-methylphenyl and one of the hydrogens attached to the nitrogen is substituted by 2-(3,4-dimethoxyphenyl)ethyl. A beta1 adrenoceptor antagonist, it has been shown to be as effective as other beta-blockers for the treatment of angina pectoris and hypertension.

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bowles, MJ1
Khurmi, NS1
O'Hara, MJ1
Raftery, EB2
Rodrigues, EA1
Lawrence, JD1
Dasgupta, P1
Hains, AD1
Lahiri, A1
Wilkinson, PR1

Trials

2 trials available for bevantolol and Chronic Disease

ArticleYear
Usefulness of bevantolol for chronic, stable angina pectoris.
    The American journal of cardiology, 1986, Nov-26, Volume: 58, Issue:12

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Chronic Disease; Double-Blind Method; Dru

1986
Comparison of bevantolol and atenolol in chronic stable angina.
    The American journal of cardiology, 1988, Jun-01, Volume: 61, Issue:15

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Chronic Disease; Clinical Trial

1988